These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38198881)

  • 1. Association between serum insulin-like growth factor 1 levels and the improvements of cognitive impairments in a subgroup of schizophrenia: Preliminary findings.
    Xiong J; Ding Y; Wu X; Zhan J; Wan Q; Wan H; Wei B; Chen H; Yang Y
    Schizophr Res; 2024 Feb; 264():282-289. PubMed ID: 38198881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia.
    Chao XL; Jiang SZ; Xiong JW; Zhan JQ; Yan K; Yang YJ; Jiang LP
    Psychiatry Res; 2020 Mar; 285():112731. PubMed ID: 31839419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia.
    Yang YJ; Luo T; Zhao Y; Jiang SZ; Xiong JW; Zhan JQ; Yu B; Yan K; Wei B
    PLoS One; 2020; 15(3):e0226688. PubMed ID: 32191705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum IGFBP-1 levels correlate with cognitive deficits in treatment-resistant and chronic medicated schizophrenia patients.
    Yang H; Yang M; Zhang Y; Shi Z; Zhang X; Zhang C
    Cytokine; 2024 Oct; 182():156728. PubMed ID: 39126767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of peripheral insulin-like growth factor 1 levels in schizophrenia.
    Pejcic AV; Jankovic SM; Janjic V; Djordjic M; Milosavljevic JZ; Milosavljevic MN
    Brain Behav; 2023 Jan; 13(1):e2819. PubMed ID: 36448977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty T; Gangadhar BN
    Schizophr Res; 2010 Jun; 119(1-3):131-7. PubMed ID: 20226630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics.
    Chao XL; Jiang SZ; Xiong JW; Zhan JQ; Wei B; Chen CN; Yang YJ
    Curr Med Sci; 2020 Jun; 40(3):563-569. PubMed ID: 32681260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor-I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function.
    Kimoto A; Kasanuki K; Kumagai R; Shibata N; Ichimiya Y; Arai H
    Psychogeriatrics; 2016 Jul; 16(4):247-54. PubMed ID: 26439951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Naveen MN; Thirthall J; Gangadhar BN; Shetty KT
    Am J Psychiatry; 2007 Oct; 164(10):1557-60. PubMed ID: 17898347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
    Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
    PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings.
    Okamoto N; Yoshino K; Kitagawa S; Fujii R; Hamada S; Ikenouchi A; Konishi Y; Ueda N; Eto Y; Tsutsumi Y; Yoshimura R
    Front Psychiatry; 2021; 12():653802. PubMed ID: 33746806
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naïve patients with psychosis.
    Petrikis P; Boumba VA; Tzallas AT; Voulgari PV; Archimandriti DT; Skapinakis P; Mavreas V
    Psychiatry Res; 2016 Dec; 246():348-352. PubMed ID: 27764741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson's disease patients.
    Shi X; Zheng J; Ma J; Li D; Gu Q; Chen S; Wang Z; Sun W; Li M
    Neurol Sci; 2023 Mar; 44(3):881-887. PubMed ID: 36383265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients.
    Palomino A; González-Pinto A; Martinez-Cengotitabengoa M; Ruiz de Azua S; Alberich S; Mosquera F; Matute C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():29-33. PubMed ID: 23337034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Huang R; Wang P; Han J; Xia W; Cai R; Sun H; Sun J; Wang S
    J Alzheimers Dis; 2015; 47(1):85-94. PubMed ID: 26402757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.
    Fernández-Pereira C; Penedo MA; Rivera-Baltanas T; Fernández-Martínez R; Ortolano S; Olivares JM; Agís-Balboa RC
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
    Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.